Drugs that reduce transmission of falciparum malaria
- PMID: 29422385
- PMCID: PMC5985155
- DOI: 10.1016/S1473-3099(18)30070-7
Drugs that reduce transmission of falciparum malaria
Conflict of interest statement
We declare no competing interests. RNP is a Wellcome Trust Senior Research Fellow in Clinical Science and NJW is a Wellcome Trust Principal Fellow and a member of the WHO Antimalarial Treatment Guidelines Committee.
Comment on
-
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.Lancet Infect Dis. 2018 Jun;18(6):627-639. doi: 10.1016/S1473-3099(18)30044-6. Epub 2018 Feb 6. Lancet Infect Dis. 2018. PMID: 29422384 Free PMC article. Clinical Trial.
References
-
- Coulibaly B, Pritsch M, Bountogo M, et al. Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso. J Infect Dis. 2015;211:689–97. - PubMed
-
- Guttmann P, Ehrlich P. Ueber die wirkung des methylenblau bei malaria. Berlin Klin Wochenschr. 1891;28:953–56. in German.
-
- Dicko A, Roh ME, Diawara H, et al. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial. Lancet Infect Dis. 2018 doi: 10.1016/S1473-3099(18)30044-6. published online Feb 5. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
